Turkish translation, cultural adaptation, and validation of the patient-reported Villalta scale for the diagnosis of postthrombotic syndrome in patients with vascular Behçet disease
Authors:
- Tuğçe Kübra GüneşTGTuğçe Kübra Güneş
- Murat KarabacakMKMurat Karabacak
- Mehmet Umut ÇaparMÇMehmet Umut Çapar
- Tüli̇n ErgunTETüli̇n Ergun
- Rafi̇ Haner Di̇rEskeneli̇RDRafi̇ Haner Di̇rEskeneli̇
- Fatma Ali̇bAz ÖnerFÖFatma Ali̇bAz Öner
Open Access
- 15 October 2026
- journal article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (5) , 1420-1429
Abstract
Background/aim: Lower extremity deep vein thrombosis (DVT) constitutes 70% of all vascular findings related to Behçet disease (BD). Postthrombotic syndrome (PTS) is a serious complication of DVT that develops due to chronic venous insufficiency and decreases the patient’s quality of life. The physician-reported Villalta scale is a widely used and validated diagnostic tool for diagnosing and evaluating the severity of PTS. However, the necessity of physical examination by a physician burdens the clinician during routine practice. For that reason, a patient-reported Villalta scale was developed and validated. This study aimed to translate the patient-reported Villalta scale into Turkish and validate it. Materials and methods: All patients were evaluated using the physician-reported Villalta scale, Clinical-Etiological-Anatomical- Pathophysiological (CEAP) classification, Venous Clinical Severity Score (VCSS), Venous Disability Score (VDS), and patient-reported Villalta scale to diagnose PTS. The VEINES questionnaire and SF-36 were used to evaluate quality of life. Kappa and correlation analysis were performed for validation analysis. Results: One hundred patients with a history of DVT were enrolled in the study, 78 of whom were followed for BD. PTS developed in 52.5% of BD patients with DVT, which was significantly lower compared to non-BD patients (77.3%) (p = 0.038). PTS was detected in 58% (n = 58) of all patients. In kappa compliance analysis of the physician-reported and patient-reported Villalta scales, good agreement was observed (κ = 0.776, p < 0.001). Between the patient-reported and physician-reported Villalta scales, sensitivity was 98%, specificity 76%, positive predictive value 85%, and negative predictive value 97%. Conclusion: This study aimed to validate the Turkish version of the patient-reported Villalta scale to diagnose PTS. The Turkish version of the patient-reported Villalta scale can reliably and validly diagnose PTS. Its application in daily practice may offer useful guidance for clinicians.Keywords
This publication has 19 references indexed in Scilit:
- External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic SyndromeThrombosis and Haemostasis, 2022
- Rivaroxaban versus warfarin for the prevention of post-thrombotic syndromeThrombosis Research, 2018
- Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's diseaseJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2016
- Scoring systems for the post-thrombotic syndromeJournal of Vascular Surgery, 2013
- Revision of the venous clinical severity score: Venous outcomes consensus statement: Special communication of the American Venous Forum Ad Hoc Outcomes Working GroupJournal of Vascular Surgery, 2010
- VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosisJournal of Clinical Epidemiology, 2006
- Reliability and construct validity of the SF-36 in Turkish cancer patientsQuality of Life Research, 2005
- Revision of the CEAP classification for chronic venous disorders: Consensus statementJournal of Vascular Surgery, 2004
- Effect of Postthrombotic Syndrome on Health-Related Quality of Life After Deep Venous ThrombosisArchives of internal medicine (1960), 2002
- Criteria for diagnosis of Behcet's diseaseThe Lancet, 1990